Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11959607rdf:typepubmed:Citationlld:pubmed
pubmed-article:11959607lifeskim:mentionsumls-concept:C0019169lld:lifeskim
pubmed-article:11959607lifeskim:mentionsumls-concept:C0019682lld:lifeskim
pubmed-article:11959607lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:11959607lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:11959607lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:11959607lifeskim:mentionsumls-concept:C0035379lld:lifeskim
pubmed-article:11959607lifeskim:mentionsumls-concept:C0209738lld:lifeskim
pubmed-article:11959607lifeskim:mentionsumls-concept:C0151317lld:lifeskim
pubmed-article:11959607lifeskim:mentionsumls-concept:C0540694lld:lifeskim
pubmed-article:11959607lifeskim:mentionsumls-concept:C0683598lld:lifeskim
pubmed-article:11959607lifeskim:mentionsumls-concept:C0332154lld:lifeskim
pubmed-article:11959607lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:11959607lifeskim:mentionsumls-concept:C0439210lld:lifeskim
pubmed-article:11959607lifeskim:mentionsumls-concept:C0332173lld:lifeskim
pubmed-article:11959607pubmed:issue5lld:pubmed
pubmed-article:11959607pubmed:dateCreated2002-4-17lld:pubmed
pubmed-article:11959607pubmed:abstractTextAdefovir dipivoxil (ADV) at a suboptimal concentration for human immunodeficiency virus type 1 (HIV-1) (10 mg once daily) can be used to treat hepatitis B virus (HBV) infection in HIV-1-HBV-coinfected patients and does not, even in the case of uncontrolled HIV-1 replication, select for either ADV mutations at codons 65 and 70 or any other particular HIV-1 reverse transcriptase resistance profile.lld:pubmed
pubmed-article:11959607pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11959607pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11959607pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11959607pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11959607pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11959607pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11959607pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11959607pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11959607pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11959607pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11959607pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11959607pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11959607pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11959607pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11959607pubmed:languageenglld:pubmed
pubmed-article:11959607pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11959607pubmed:citationSubsetIMlld:pubmed
pubmed-article:11959607pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11959607pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11959607pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11959607pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11959607pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11959607pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11959607pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11959607pubmed:statusMEDLINElld:pubmed
pubmed-article:11959607pubmed:monthMaylld:pubmed
pubmed-article:11959607pubmed:issn0066-4804lld:pubmed
pubmed-article:11959607pubmed:authorpubmed-author:ThibaultVince...lld:pubmed
pubmed-article:11959607pubmed:authorpubmed-author:KatlamaChrist...lld:pubmed
pubmed-article:11959607pubmed:authorpubmed-author:DelaugerreCon...lld:pubmed
pubmed-article:11959607pubmed:authorpubmed-author:CalvezVincent...lld:pubmed
pubmed-article:11959607pubmed:authorpubmed-author:PeytavinGille...lld:pubmed
pubmed-article:11959607pubmed:authorpubmed-author:MarcelinAnne-...lld:pubmed
pubmed-article:11959607pubmed:authorpubmed-author:BombledTonyTlld:pubmed
pubmed-article:11959607pubmed:authorpubmed-author:BochetMarie-V...lld:pubmed
pubmed-article:11959607pubmed:authorpubmed-author:BenhamouYvesYlld:pubmed
pubmed-article:11959607pubmed:issnTypePrintlld:pubmed
pubmed-article:11959607pubmed:volume46lld:pubmed
pubmed-article:11959607pubmed:ownerNLMlld:pubmed
pubmed-article:11959607pubmed:authorsCompleteYlld:pubmed
pubmed-article:11959607pubmed:pagination1586-8lld:pubmed
pubmed-article:11959607pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:11959607pubmed:meshHeadingpubmed-meshheading:11959607...lld:pubmed
pubmed-article:11959607pubmed:meshHeadingpubmed-meshheading:11959607...lld:pubmed
pubmed-article:11959607pubmed:meshHeadingpubmed-meshheading:11959607...lld:pubmed
pubmed-article:11959607pubmed:meshHeadingpubmed-meshheading:11959607...lld:pubmed
pubmed-article:11959607pubmed:meshHeadingpubmed-meshheading:11959607...lld:pubmed
pubmed-article:11959607pubmed:meshHeadingpubmed-meshheading:11959607...lld:pubmed
pubmed-article:11959607pubmed:meshHeadingpubmed-meshheading:11959607...lld:pubmed
pubmed-article:11959607pubmed:meshHeadingpubmed-meshheading:11959607...lld:pubmed
pubmed-article:11959607pubmed:meshHeadingpubmed-meshheading:11959607...lld:pubmed
pubmed-article:11959607pubmed:meshHeadingpubmed-meshheading:11959607...lld:pubmed
pubmed-article:11959607pubmed:meshHeadingpubmed-meshheading:11959607...lld:pubmed
pubmed-article:11959607pubmed:meshHeadingpubmed-meshheading:11959607...lld:pubmed
pubmed-article:11959607pubmed:meshHeadingpubmed-meshheading:11959607...lld:pubmed
pubmed-article:11959607pubmed:meshHeadingpubmed-meshheading:11959607...lld:pubmed
pubmed-article:11959607pubmed:year2002lld:pubmed
pubmed-article:11959607pubmed:articleTitleHuman immunodeficiency virus (HIV) Type 1 reverse transcriptase resistance mutations in hepatitis B virus (HBV)-HIV-coinfected patients treated for HBV chronic infection once daily with 10 milligrams of adefovir dipivoxil combined with lamivudine.lld:pubmed
pubmed-article:11959607pubmed:affiliationDepartment of Virology, Pitié-Salpêtrière Hospital, Paris, France.lld:pubmed
pubmed-article:11959607pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11959607lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11959607lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11959607lld:pubmed